Related Experiment Video
Updated: May 30, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Emerging practice patterns and outcomes of percutaneous aortic balloon valvuloplasty in patients with severe aortic
Rony D Gorges1, Peter Burke, Wadie David
1Providence Heart Institute, Providence Hospital and Medical Center, Southfield, MI, USA.
Abstract:
A total of 33 patients with severe aortic stenosis undergoing percutaneous aortic balloon valvuloplasty (PABV) for bridging or palliative therapy were reviewed; the emerging treatment patterns for this procedure are described. Longitudinal data suggest that PABV provides a significant reduction in peak and mean aortic valve gradients with > 12-month survival for more than half of observed patients. This supports the current application of PABV, which is currently limited to palliative care and bridging therapy to more definitive forms of future treatment, including transcatheter aortic valve implantation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
